Last quarter (Q4 2023), West Pharmaceutical Services's total revenue was $732.00M, an increase of 3.29% from the same quarter last year. In Q4, West Pharmaceutical Services's net income was $125.80M. See West Pharmaceutical Services’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 2.95B	$ 2.95B	$ 2.89B	$ 2.83B	$ 2.15B	$ 1.84B
Cost of Revenue	$ 1.82B	$ 1.82B	$ 1.75B	$ 1.66B	$ 1.38B	$ 1.23B
Gross Profit	$ 1.13B	$ 1.13B	$ 1.14B	$ 1.18B	$ 767.80M	$ 605.70M
Operating Expense	$ 390.40M	$ 390.40M	$ 402.20M	$ 423.50M	$ 348.90M	$ 306.90M
Operating Income	$ 676.00M	$ 676.00M	$ 734.00M	$ 752.30M	$ 418.90M	$ 298.80M
Net Non Operating Interest Income Expense	$ -9.00M	$ -9.00M	$ -2.80M	$ -7.20M	$ -6.80M	$ -4.70M
Other Income Expense	$ -48.70M	$ -48.70M	$ 30.60M	$ -23.90M	$ -10.80M	$ -2.30M
Pretax Income	$ 698.00M	$ 698.00M	$ 700.60M	$ 769.00M	$ 401.30M	$ 291.80M
Tax Provision	$ 122.30M	$ 122.30M	$ 114.70M	$ 107.20M	$ 72.50M	$ 59.00M
Earnings From Equity Interest Net Of Tax	$ 17.70M	$ 17.70M	$ 20.70M	$ 20.10M	$ 17.40M	$ 8.90M
Net Income Common Stockholders	$ 593.40M	$ 593.40M	$ 585.90M	$ 661.80M	$ 346.20M	$ 241.70M
Basic EPS	$ 7.98	$ 7.98	$ 7.87	$ 8.89	$ 4.68	$ 3.27
Diluted EPS	$ 7.88	$ 7.88	$ 7.73	$ 8.67	$ 4.57	$ 3.21
Basic Average Shares	$ 297.20M	$ 74.30M	$ 74.40M	$ 74.40M	$ 73.90M	$ 74.00M
Diluted Average Shares	$ 301.20M	$ 75.30M	$ 75.80M	$ 76.30M	$ 75.80M	$ 75.40M
Dividend Per Share	$ 0.78	$ 0.78	$ 0.74	$ 0.70	$ 0.65	$ 0.61
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	$ 4.76	$ 3.24
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 2.21B	$ 2.21B	$ 2.15B	$ 2.08B	$ 1.73B	$ 1.54B
Net Income From Continuing And Discontinued Operation	$ 593.40M	$ 593.40M	$ 585.90M	$ 661.80M	$ 346.20M	$ 241.70M
Normalized Income	$ 454.48M	$ 572.12M	-	-	$ 356.03M	$ 245.05M
Interest Expense	-	-	-	-	$ 8.20M	$ 8.50M
EBIT	$ 707.00M	$ 707.00M	$ 708.50M	$ 777.20M	$ 409.50M	$ 300.30M
EBITDA	$ 844.30M	$ 844.30M	$ 829.10M	$ 899.50M	$ 518.60M	$ 403.70M

Currency in USD

West Pharmaceutical Services Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing